Mucins and mucinous ovarian carcinoma: Development, differential diagnosis, and treatment

Heliyon. 2023 Aug 17;9(8):e19221. doi: 10.1016/j.heliyon.2023.e19221. eCollection 2023 Aug.

Abstract

Mucinous ovarian carcinoma (MOC) is a rare histological type of epithelial ovarian cancer. It has poor response to conventional platinum-based chemotherapy regimens and PARPi-based maintenance treatment, resulting in short survival and poor prognosis in advanced-disease patients. MOC is characterized by mucus that is mainly composed of mucin in the cystic cavity. Our review discusses in detail the role of mucins in MOC. Mucins are correlated with MOC development. Furthermore, they are valuable in the differential diagnosis of primary and secondary ovarian mucinous tumors. Some types of mucins have been studied in the context of chemoresistance and targeted therapy for ovarian cancer. This review may provide a new direction for the diagnosis and treatment of advanced MOC.

Keywords: Chemoresistance; Mucin; Mucinous ovarian carcinoma; Targeted therapy; Tumorigenesis.

Publication types

  • Review